P. Burgel (Paris, France), B. Plant (Cork, Ireland)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Proteomic analysis uncovers distinct signatures of bacterial-viral coinfections in cystic fibrosis cells
A. Endres (Frankfurt am Main, Germany), P. Kastl (Lyngby, Denmark), H. Boland (Frankfurt am Main, Germany), C. Hügel (Frankfurt am Main, Germany), K. Kalogeropoulos (Lyngby, Denmark), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), U. Auf Dem Keller (Lyngby, Denmark), C. Bellinghausen (Frankfurt am Main, Germany)
|    |
Serine protease-dependent degradation of IL-6 by Pseudomonas aeruginosa in an in vitro model of bacterial-viral coinfection
A. Endres (Frankfurt am Main, Germany), H. Boland (Frankfurt am Main, Germany), C. Hügel (Frankfurt am Main, Germany), R. Schubert (Frankfurt am Main, Germany), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), C. Bellinghausen (Frankfurt am Main, Germany)
| |
Frequency and phenotypical alterations of unconventional T cells in cystic fibrosis
P. Tossan (Tours, France), S. Legue (Tours, France), L. Gonzalez (Tours, France), T. Flament (Tours, France), J. Mankikian (Tours, France), Y. Jouan (Tours, France), A. Guillon (Tours, France), M. Si-Tahar (Tours, France), C. Paget (Tours, France)
| |
Aspergillus pulmonary disease in cystic fibrosis (CF) patients: multicentre perspective observational study based on new diagnostic tests to evaluate the prognostic value on the CF disease
J. Mencarini (Florence, Italy), E. Fiscarelli (Rome, Italy), L. Cariani (Milan, Italy), G. Linardos (Rome, Italy), D. Girelli (Milan, Italy), M. Rossitto (Rome, Italy), S. Pollini (Florence, Italy), A. Teri (Milan, Italy), G. Taccetti (Florence, Italy), A. Bartoloni (Florence, Italy), S. Bresci (Florence, Italy)
| |
Chronic Pseudomonas aeruginosa lung infection, but not CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis
D. Westhölter (Essen, Germany), H. Beckert (Essen, Germany), S. Strassburg (Essen, Germany), M. Welsner (Essen, Germany), S. Sutharsan (Essen, Germany), C. Taube (Essen, Germany), S. Reuter (Essen, Germany)
| |
Could a 2-year mortality prediction model have prevented deaths from respiratory failure: a single UK centre experience
K. Dave (London, United Kingdom), R. Dunk (London, United Kingdom), S. Madge (London, United Kingdom), V. Gerovasili (London, United Kingdom), A. Reed (London, United Kingdom), N. Simmonds (London, United Kingdom)
| |
Discussion
| |